Ozone nanobubble treatments improve survivability of Nile tilapia (Oreochromis niloticus) challenged with a pathogenic multi-drug-resistant Aeromonas hydrophila

© 2021 John Wiley & Sons Ltd.

Bibliographische Detailangaben
Veröffentlicht in:Journal of fish diseases. - 1998. - 44(2021), 9 vom: 05. Sept., Seite 1435-1447
1. Verfasser: Thanh Dien, Le (VerfasserIn)
Weitere Verfasser: Linh, Nguyen Vu, Sangpo, Pattiya, Senapin, Saengchan, St-Hilaire, Sophie, Rodkhum, Channarong, Dong, Ha Thanh
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Journal of fish diseases
Schlagworte:Journal Article Aeromonas hydrophila antimicrobial resistance multidrug resistance non-antibiotic approach ozone nanobubbles Ozone 66H7ZZK23N
LEADER 01000naa a22002652 4500
001 NLM326621997
003 DE-627
005 20231225195005.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1111/jfd.13451  |2 doi 
028 5 2 |a pubmed24n1088.xml 
035 |a (DE-627)NLM326621997 
035 |a (NLM)34114245 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Thanh Dien, Le  |e verfasserin  |4 aut 
245 1 0 |a Ozone nanobubble treatments improve survivability of Nile tilapia (Oreochromis niloticus) challenged with a pathogenic multi-drug-resistant Aeromonas hydrophila 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.11.2021 
500 |a Date Revised 01.11.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2021 John Wiley & Sons Ltd. 
520 |a A rapid increase in multi-drug-resistant (MDR) bacteria in aquaculture highlights the risk of production losses due to diseases and potential public health concerns. Previously, we reported that ozone nanobubbles (NB-O3 ) were effective at reducing concentrations of pathogenic bacteria in water and modulating fish immunity against pathogens; however, multiple treatments with direct NB-O3 exposures caused alterations to the gills of exposed fish. Here, we set up a modified recirculation system (MRS) assembled with an NB-O3 device (MRS-NB-O3 ) to investigate whether MRS-NB-O3 (a) were safe for tilapia (Oreochromis niloticus), (b) were effective at reducing bacterial load in rearing water and (c) improved survivability of Nile tilapia following an immersion challenge with a lethal dose of MDR Aeromonas hydrophila. The results showed no behavioural abnormalities or mortality of Nile tilapia during the 14-day study using the MRS-NB-O3 system. In the immersion challenge, although high bacterial concentration (~2 × 107  CFU/ml) was used, multiple NB-O3 treatments in the first two days reduced the bacteria between 15.9% and 35.6% of bacterial load in water, while bacterial concentration increased from 13.1% to 27.9% in the untreated control. There was slight up-regulation of non-specific immune-related genes in the gills of the fish receiving NB-O3 treatments. Most importantly, this treatment significantly improved survivability of Nile tilapia with relative percentage survival (RPS) of 64.7% - 66.7% in treated fish and surviving fish developed specific antibody against MDR A. hydrophila. In summary, the result suggests that NB-O3 is a promising non-antibiotic approach to control bacterial diseases, including MDR bacteria, and has high potential for application in recirculation aquaculture system (RAS) 
650 4 |a Journal Article 
650 4 |a Aeromonas hydrophila 
650 4 |a antimicrobial resistance 
650 4 |a multidrug resistance 
650 4 |a non-antibiotic approach 
650 4 |a ozone nanobubbles 
650 7 |a Ozone  |2 NLM 
650 7 |a 66H7ZZK23N  |2 NLM 
700 1 |a Linh, Nguyen Vu  |e verfasserin  |4 aut 
700 1 |a Sangpo, Pattiya  |e verfasserin  |4 aut 
700 1 |a Senapin, Saengchan  |e verfasserin  |4 aut 
700 1 |a St-Hilaire, Sophie  |e verfasserin  |4 aut 
700 1 |a Rodkhum, Channarong  |e verfasserin  |4 aut 
700 1 |a Dong, Ha Thanh  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of fish diseases  |d 1998  |g 44(2021), 9 vom: 05. Sept., Seite 1435-1447  |w (DE-627)NLM098166034  |x 1365-2761  |7 nnns 
773 1 8 |g volume:44  |g year:2021  |g number:9  |g day:05  |g month:09  |g pages:1435-1447 
856 4 0 |u http://dx.doi.org/10.1111/jfd.13451  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 44  |j 2021  |e 9  |b 05  |c 09  |h 1435-1447